Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises in conjunction with sale of shares in Embellence Group
Mandate

Vinge advises in conjunction with sale of shares in Embellence Group

December 13, 2021 Capital Markets and Public M&A M&A

Vinge has advised Litorina CoInvest 1 AB in conjunction with the sale of 10.5 percent of the shares and votes in Embellence Group AB (publ) to JCE Asset Management AB.

Embellence Group is a leading European company in the premium wallpaper segment and has a prominent position internationally with sales in over 90 countries. Embellence Group is listed on Nasdaq First North Premier.

Vinge’s team consisted of Johan Winnerblad, Rikard Lindahl and Joel Magnusson.

Related

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025